Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A micro-dilution technique with changes in optical density (OD) used to measure bacterial growth over 72 h in culture media containing 0, 5, 10, 20, 40, 80 and 160 microg
OTC
(oxytetracycline)ml(-1) was applied to determine growth inhibition (GI) in mixed bacterial strains cultured from samples of marine sediments and salmon feed pellets. Growth of control cultures (Aeromonas salmonicida) was inhibited at all
OTC
concentrations. Some feed pellet samples and under-
cage
sediments from salmon aquaculture sites in the Bay of Fundy showed GI up to > or = 160 microg OTCml(-1). Lower values (40 to 80 microg
OTC
ml(-1)) occurred in subsurface (5-18 cm) sediments, > 100 m from salmon pens and adjacent to sewage outfalls in Halifax Harbour. GI values < 20 microg
OTC
ml(-1) in sediment from reference locations in Halifax Harbour and mussel aquaculture sites are considered to reflect natural background levels for
OTC
resistance.
...
PMID:A micro-dilution method for detecting oxytetracycline-resistant bacteria in marine sediments from salmon and mussel aquaculture sites and an urbanized harbour in Atlantic Canada. 1858 56
Hepatocellular carcinoma (HCC) is one of the leading causes of
cancer-associated
mortalities worldwide. The role of
ornithine transcarbamylase
(
OTC
) in HCC remains unclear. In the present study, the expression of
OTC
in HCC was analyzed based on datasets from the Gene Expression Omnibus database of the National Center for Biotechnology Information and further confirmed by immunohistochemistry, western blotting analysis and reverse transcription-quantitative polymerase chain reaction assays on clinical samples and cell lines. Furthermore, the associations between
OTC
expression and clinicopathological parameters as well as clinical outcome, including the overall and disease-free survival rates were analyzed. Finally, the effect of
OTC
on HCC cells was measured using proliferation, bromodeoxyuridine and colony-formation assays. Lower
OTC
expression was observed in HCC cells and tissues compared with primary human hepatocytes. Further investigation demonstrated that low expression of
OTC
in HCC was associated with larger tumor size and advanced grade. A Kaplan-Meier analysis revealed that patients with lower levels of
OTC
exhibited shorter overall and disease-free survival times. Notably,
OTC
silencing with RNA interference facilitated cell proliferation in HCC SK-Hep-1 and Huh-7 cells. However, overexpression of
OTC
led to inhibition of cell proliferation. In conclusion, the present study identified a novel role of
OTC
in HCC development, providing a potential novel therapeutic target for this disease.
...
PMID:Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma. 3118 14